Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386879574> ?p ?o ?g. }
- W4386879574 endingPage "14315" @default.
- W4386879574 startingPage "14315" @default.
- W4386879574 abstract "Facial seborrheic dermatitis (SD) is an inflammatory skin disease characterized by erythematous and scaly lesions on the skin with high sebaceous gland activity. The yeast Malassezia is regarded as a key pathogenic driver in this disease, but increased Staphylococcus abundances and barrier dysfunction are implicated as well. Here, we evaluated the antimicrobial peptide omiganan as a treatment for SD since it has shown both antifungal and antibacterial activity. A randomized, patient- and evaluator-blinded trial was performed comparing the four-week, twice daily topical administration of omiganan 1.75%, the comparator ketoconazole 2.00%, and placebo in patients with mild-to-moderate facial SD. Safety was monitored, and efficacy was determined by clinical scoring complemented with imaging. Microbial profiling was performed, and barrier integrity was assessed by trans-epidermal water loss and ceramide lipidomics. Omiganan was safe and well tolerated but did not result in a significant clinical improvement of SD, nor did it affect other biomarkers, compared to the placebo. Ketoconazole significantly reduced the disease severity compared to the placebo, with reduced Malassezia abundances, increased microbial diversity, restored skin barrier function, and decreased short-chain ceramide Cer[NSc34]. No significant decreases in Staphylococcus abundances were observed compared to the placebo. Omiganan is well tolerated but not efficacious in the treatment of facial SD. Previously established antimicrobial and antifungal properties of omiganan could not be demonstrated. Our multimodal characterization of the response to ketoconazole has reaffirmed previous insights into its mechanism of action." @default.
- W4386879574 created "2023-09-21" @default.
- W4386879574 creator A5010829909 @default.
- W4386879574 creator A5016443532 @default.
- W4386879574 creator A5017613866 @default.
- W4386879574 creator A5034820865 @default.
- W4386879574 creator A5040705335 @default.
- W4386879574 creator A5044043547 @default.
- W4386879574 creator A5056532501 @default.
- W4386879574 creator A5059514472 @default.
- W4386879574 creator A5072790675 @default.
- W4386879574 creator A5073070631 @default.
- W4386879574 creator A5082089875 @default.
- W4386879574 creator A5082092098 @default.
- W4386879574 creator A5083164288 @default.
- W4386879574 creator A5084538260 @default.
- W4386879574 creator A5092906630 @default.
- W4386879574 date "2023-09-20" @default.
- W4386879574 modified "2023-10-17" @default.
- W4386879574 title "Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept Trial" @default.
- W4386879574 cites W1535987576 @default.
- W4386879574 cites W1979720594 @default.
- W4386879574 cites W1986448187 @default.
- W4386879574 cites W2007006086 @default.
- W4386879574 cites W2007393113 @default.
- W4386879574 cites W2054031432 @default.
- W4386879574 cites W2054083814 @default.
- W4386879574 cites W2060581001 @default.
- W4386879574 cites W2061177996 @default.
- W4386879574 cites W2093066805 @default.
- W4386879574 cites W2096991001 @default.
- W4386879574 cites W2097088367 @default.
- W4386879574 cites W2097414721 @default.
- W4386879574 cites W2100803603 @default.
- W4386879574 cites W2107135756 @default.
- W4386879574 cites W2125167335 @default.
- W4386879574 cites W2130942098 @default.
- W4386879574 cites W2151189567 @default.
- W4386879574 cites W2151350595 @default.
- W4386879574 cites W2169873778 @default.
- W4386879574 cites W2334399810 @default.
- W4386879574 cites W2345819870 @default.
- W4386879574 cites W2460445544 @default.
- W4386879574 cites W2471495572 @default.
- W4386879574 cites W2509354975 @default.
- W4386879574 cites W2586770695 @default.
- W4386879574 cites W2614795271 @default.
- W4386879574 cites W273205602 @default.
- W4386879574 cites W2767768013 @default.
- W4386879574 cites W2773553976 @default.
- W4386879574 cites W2789670381 @default.
- W4386879574 cites W2801330361 @default.
- W4386879574 cites W2809796857 @default.
- W4386879574 cites W2922478983 @default.
- W4386879574 cites W2940897784 @default.
- W4386879574 cites W2957851515 @default.
- W4386879574 cites W2961089596 @default.
- W4386879574 cites W2975867000 @default.
- W4386879574 cites W2978793169 @default.
- W4386879574 cites W2987779885 @default.
- W4386879574 cites W2989616181 @default.
- W4386879574 cites W3013877382 @default.
- W4386879574 cites W3016513521 @default.
- W4386879574 cites W3017322438 @default.
- W4386879574 cites W3034702024 @default.
- W4386879574 cites W3081957651 @default.
- W4386879574 cites W3086151842 @default.
- W4386879574 cites W3091193639 @default.
- W4386879574 cites W3092940014 @default.
- W4386879574 cites W3098208204 @default.
- W4386879574 cites W3118781193 @default.
- W4386879574 cites W3165670794 @default.
- W4386879574 cites W3178656401 @default.
- W4386879574 cites W3195308333 @default.
- W4386879574 cites W3216225379 @default.
- W4386879574 cites W4205906583 @default.
- W4386879574 cites W4210558240 @default.
- W4386879574 cites W4235106149 @default.
- W4386879574 cites W4285043297 @default.
- W4386879574 cites W4295086513 @default.
- W4386879574 cites W4365443549 @default.
- W4386879574 cites W4372204077 @default.
- W4386879574 cites W4379880024 @default.
- W4386879574 cites W52022457 @default.
- W4386879574 doi "https://doi.org/10.3390/ijms241814315" @default.
- W4386879574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37762625" @default.
- W4386879574 hasPublicationYear "2023" @default.
- W4386879574 type Work @default.
- W4386879574 citedByCount "0" @default.
- W4386879574 crossrefType "journal-article" @default.
- W4386879574 hasAuthorship W4386879574A5010829909 @default.
- W4386879574 hasAuthorship W4386879574A5016443532 @default.
- W4386879574 hasAuthorship W4386879574A5017613866 @default.
- W4386879574 hasAuthorship W4386879574A5034820865 @default.
- W4386879574 hasAuthorship W4386879574A5040705335 @default.
- W4386879574 hasAuthorship W4386879574A5044043547 @default.
- W4386879574 hasAuthorship W4386879574A5056532501 @default.
- W4386879574 hasAuthorship W4386879574A5059514472 @default.